Drugs: Biotechnology

Drugs: Biotechnology - This stock sector includes companies that develop and manufacture biotechnology drugs, such as genetically engineered proteins and monoclonal antibodies, as well as related services.

CRL Charles River Laboratories International Inc. is a contract research organization that provides drug discovery and development services to the pharmaceutical and biotechnology industries, as well as academic institutions and government agencies worldwide.

IBIO iBio Inc. is a biotechnology company focused on developing and commercializing plant-based biologics and vaccines, dedicated to transforming the way medicines are discovered, developed, and manufactured.

CYCC Cyclacel Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that develops and commercializes small-molecule drugs to treat cancer and other serious diseases.

CRMD CorMedix Inc. is a biopharmaceutical company that develops and commercializes therapeutic products for the prevention and treatment of infectious and inflammatory diseases, focusing on the hospital and acute care markets.

CVM Cel-Sci Corporation: A biotechnology company that develops immunotherapy products for the treatment of cancer and infectious diseases, primarily in the United States.

RGEN Repligen Corp. is a bioprocessing company that develops and produces products for the biopharmaceutical industry, including chromatography resins, filtration products, and protein A affinity ligands.

PRPH ProPhase Labs Inc. is a healthcare company that develops and markets over-the-counter and prescription medications for common cold and cough, as well as dietary supplements. The company's products are sold under the Cold-EEZE, Kids-EEZE, and Organixx brands.

NVAX Novavax, Inc. is a clinical-stage biotechnology company that develops various vaccines for infectious diseases, including COVID-19.

BMRN BioMarin Pharmaceutical Inc. is a biotechnology company that develops and commercializes therapies for rare genetic diseases. The company's products are used to treat a range of rare diseases, including hemophilia, phenylketonuria, and achondroplasia. BioMarin is a leader in the field of rare disease research and has a strong pipeline of potential therapies in development.

OMER Omeros Corp. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of small-molecule and protein therapeutics.

ONCY Oncolytics Biotech Inc. is a clinical-stage biotechnology company that focuses on developing oncolytic viruses as potential cancer therapeutics.

QGEN Qiagen NV is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company's products include sample preparation kits, PCR assays, and bioinformatics software.

MNKD MannKind Corporation is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for diabetes and pulmonary arterial hypertension.

GILD Gilead Sciences Inc. is a biopharmaceutical company that develops and commercializes various products and therapies, including treatments for HIV, liver diseases, and cancer, for various diseases and conditions worldwide.

AGEN Agenus Inc. is a biotechnology company that develops and commercializes immuno-oncology and other immunology-based therapies for the treatment of cancer and other diseases. The company's products include Prophage, AutoSynVax, and Balstilimab, among others. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

AMGN Amgen Inc. is a biotechnology company that develops and markets medicines for the treatment of cancer, cardiovascular disease, and other medical conditions. The company's products include Enbrel, Neulasta, and Prolia, among others. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

AMRS Amyris Inc. is a biotechnology company that develops and markets renewable chemicals and fuels, including biofuels and flavors and fragrances, among others. The company's products include Biofene and Biossance, among others. Amyris Inc. was founded in 2003 and is headquartered in Emeryville, California.

INO Inovio Pharmaceuticals Inc. is a biotechnology company developing DNA-based immunotherapies for the treatment of cancer and infectious diseases, with a mission to improve global health through innovation and collaboration.

CYTK Cytokinetics Inc. is a biopharmaceutical company that develops and commercializes muscle biology-driven therapies for diseases and medical conditions, including cardiovascular diseases, neuromuscular diseases, and respiratory diseases.

ILMN Illumina Inc. is a global leader in genomics and sequencing technologies, providing innovative solutions and services to enable groundbreaking discoveries and advance the understanding of human biology and disease.

EXEL Exelixis Inc. is a biopharmaceutical company that develops and commercializes therapies for the treatment of cancer and other serious diseases.

RPRX Repros Therapeutics Inc. is a biopharmaceutical company that develops and produces drugs for the treatment of hormonal and reproductive disorders.

IG IGI Laboratories Inc. is a specialty pharmaceutical company focused on the development, manufacturing, and commercialization of topical formulations for the dermatology and women's health markets, dedicated to delivering high-quality and affordable products to patients.

CORT Corcept Therapeutics Inc. is a biopharmaceutical company that develops and markets drugs for the treatment of severe metabolic and psychiatric disorders, such as Cushing's syndrome and bipolar disorder.

IDRA Idera Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for rare diseases and oncology, with a strong commitment to improving patient outcomes.

AVEO AVEO Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes cancer therapeutics. The company's lead product candidate is tivozanib, a treatment for renal cell carcinoma. AVEO Pharmaceuticals Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.

ABIO ARCA biopharma Inc. is a biopharmaceutical company that develops and commercializes genetically targeted therapies for cardiovascular diseases. The company's lead product candidate is Gencaro, a beta-blocker and mild vasodilator for the treatment of atrial fibrillation. ARCA biopharma Inc. was founded in 1998 and is headquartered in Westminster, Colorado.

ALKS Alkermes Inc. is a biopharmaceutical company that develops and markets medicines for the treatment of central nervous system disorders, including addiction and schizophrenia. The company's products include Vivitrol and Aristada, among others. Alkermes Inc. was founded in 1987 and is headquartered in Dublin, Ireland.

ALXN Alexion Pharmaceuticals Inc. is a biopharmaceutical company that develops and markets medicines for the treatment of rare diseases, including paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, among others. The company's products include Soliris and Ultomiris, among others. Alexion Pharmaceuticals Inc. was founded in 1992 and is headquartered in Boston, M

INCY Incyte Corp. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative cancer therapies, committed to improving the lives of patients and creating value for its stakeholders.

SIGA SIGA Technologies, Inc. is a pharmaceutical company focused on the development and commercialization of therapeutics to prevent and treat serious infectious diseases.

REGN Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that develops and produces drugs and therapies for a variety of medical conditions, including cancer, cardiovascular disease, and eye diseases.

BIIB Biogen Inc. is a biotechnology company focused on discovering, developing, and delivering therapies for neurological and neurodegenerative diseases worldwide.

IMGN ImmunoGen Inc. is a biotechnology company developing novel cancer therapeutics using its antibody-drug conjugate (ADC) technology, with a focus on improving patient outcomes and quality of life.

VNDA Vanda Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapies for central nervous system disorders, serving patients in the United States and internationally.

JAZZ Jazz Pharmaceuticals Inc. is a biopharmaceutical company developing and commercializing therapies for rare and serious diseases, with a focus on improving patient outcomes and quality of life.

MNOV MediciNova, Inc. is a biopharmaceutical company that develops and commercializes novel, small-molecule therapeutics for the treatment of various diseases, including neurological and inflammatory diseases.

EBS Emergent Biosolutions Inc. is a global biopharmaceutical company that develops, manufactures, and commercializes vaccines and therapeutics for infectious diseases, autoimmune disorders, and oncology.

ALNY Alnylam Pharmaceuticals Inc. is a biopharmaceutical company that develops and markets RNA interference therapeutics for the treatment of genetic diseases, including amyloidosis and hemophilia, among others. The company's products include Onpattro and Givlaari, among others. Alnylam Pharmaceuticals Inc. was founded in 2002 and is headquartered in Cambridge, Massachusetts.

VRTX Vertex Pharmaceuticals Inc. is a biotechnology company that focuses on the discovery, development, and commercialization of medicines for serious diseases such as cystic fibrosis, sickle cell disease, and beta thalassemia.

NBIX Neurocrine Biosciences, Inc. is a biopharmaceutical company that develops and commercializes various therapies for various medical fields, including neuroscience, endocrinology, and oncology.

HALO Halozyme Therapeutics Inc. is a biopharmaceutical company that develops and produces various oncology and other therapeutic products, using various proprietary technologies, for various customers and industries worldwide.

GNOM Complete Genomics Inc. is a life sciences company that provides various DNA sequencing and analysis solutions, including research, clinical, and consumer products, for various industries and customers worldwide.

XOMA XOMA Ltd is a biotechnology company developing and commercializing therapeutic antibodies and other biologic products to treat a range of diseases.

CDXS Codexis Inc. is a biotechnology company that develops protein engineering technology solutions for applications in the biotherapeutics and pharmaceuticals markets.

FOLD Amicus Therapeutics Inc. is a biotechnology company that develops therapies for rare and orphan diseases, with a focus on enzyme replacement therapies and gene therapies.

CTIC Cell Therapeutics Inc. is a biopharmaceutical company that develops and commercializes oncology treatments, focusing on the discovery and development of small-molecule drugs to treat cancer and other serious diseases.

HSKA Heska Corp. is a provider of veterinary diagnostic and specialty products for canine and feline healthcare markets.

ACAD ACADIA Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes drugs for neurological and related central nervous system disorders. The company's lead product is Nuplazid, a drug for the treatment of Parkinson's disease psychosis. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

INFI Infinity Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies, leveraging its expertise in immuno-oncology and small molecule drug discovery to improve patient outcomes.

PACB Pacific Biosciences Of California Inc. is a biotechnology company that develops and markets gene sequencing systems for scientific research and clinical diagnostics.

ANIK Anika Therapeutics Inc. is a biotechnology company that develops and markets therapeutic products for tissue protection, repair, and regeneration, including orthopedic and ophthalmic products, among others. The company's products include Orthovisc and Cingal, among others. Anika Therapeutics Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts. issouri.

SGMO Sangamo Biosciences Inc. is a clinical-stage biotechnology company focused on developing genomic therapies to treat various genetic diseases.

GERN Geron Corp. is a biotechnology company that develops and commercializes various products and therapies, including cancer treatments and stem cell therapies, for various diseases and conditions.

SGEN Seattle Genetics Inc. is a biotechnology company, developing and commercializing innovative cancer therapies based on its proprietary antibody-drug conjugate technology.

INSM Insmed Inc. is a biopharmaceutical company developing therapies for rare diseases and serious lung conditions, using its expertise in the discovery and development of novel therapeutics to improve patient outcomes and quality of life.

CRIS Curis Inc. is a biotechnology company that develops and commercializes cancer treatments, focusing on targeted therapies and immuno-oncology.

CERS Cerus Corporation is a biomedical products company engaged in the research, development, and commercialization of products intended to enhance blood safety.

ATHX Athersys Inc. is a biotechnology company that develops therapies for various medical conditions, including stroke, acute respiratory distress syndrome, and graft-versus-host disease, among others. The company's products are based on its proprietary stem cell technology. Athersys Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.

ARWR Arrowhead Research Corp. is a biopharmaceutical company that focuses on the development of RNAi-based therapeutics. The company's products are designed to treat various diseases, including cardiovascular and metabolic diseases, among others. Arrowhead Research Corp. was founded in 2007 and is headquartered in Pasadena, California.

PLX Protalix Biotherapeutics Inc. is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins for the treatment of genetic and other chronic diseases. The company's products are developed using its proprietary ProCellEx protein expression system.

ACOR Acorda Therapeutics Inc. is a biopharmaceutical company that develops and commercializes therapies for neurological disorders, including multiple sclerosis and Parkinson's disease. The company's products include Ampyra, a drug for the improvement of walking in multiple sclerosis patients. Acorda Therapeutics Inc. was founded in 1995 and is headquartered in Ardsley, New York.

CGEN Compugen Ltd is a clinical-stage biotechnology company that is engaged in the discovery and development of novel immunotherapies to treat cancer and autoimmune diseases.

SPPI Spectrum Pharmaceuticals Inc. is a biopharmaceutical company that develops and markets oncology and hematology drug products.

NEPT Neptune Wellness Solutions Inc. is a health and wellness company that develops and commercializes various products and services, including nutraceuticals, hemp-derived ingredients, and turnkey product development and supply chain solutions.

EXAS Exact Sciences Corp. is a molecular diagnostics company that develops and commercializes non-invasive screening tests for colorectal cancer and other cancers.

LXRX Lexicon Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of innovative treatments for patients with serious diseases, committed to improving patients' lives and creating value for its shareholders.

NKTR Nektar Therapeutics is a biopharmaceutical company that develops and commercializes various therapies for various medical fields, including oncology, immunology, and pain management.

BCRX BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on the development and commercialization of treatments for rare diseases. The company's pipeline includes potential therapies for angioedema, hereditary angioedema, and other rare diseases.